Matches in Nanopublications for { ?s ?p "[In addition, this gene may be responsible for a new hereditary syndrome predisposing to a variety of tumors designated rhabdoid predisposition syndrome. In the present study, we analyzed a series of 53 ependymal tumors of 48 patients [4 myxopapillary ependymomas (WHO grade I), 3 subependymomas (WHO grade I), 18 ependymomas (WHO grade II), 21 anaplastic ependymomas (WHO grade III) and 2 ependymoblastomas (WHO grade IV)] for mutations and homozygous deletions in the coding region of the hSNF5/INI1 gene and for allelic loss of its flanking chromosomal regions in 39 ependymal tumors of 35 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP329523.RAYY-fSNvdRlg3pYaHiP5wCaI6G6ibaSmMN8MrV2y7-w8130_assertion description "[In addition, this gene may be responsible for a new hereditary syndrome predisposing to a variety of tumors designated rhabdoid predisposition syndrome. In the present study, we analyzed a series of 53 ependymal tumors of 48 patients [4 myxopapillary ependymomas (WHO grade I), 3 subependymomas (WHO grade I), 18 ependymomas (WHO grade II), 21 anaplastic ependymomas (WHO grade III) and 2 ependymoblastomas (WHO grade IV)] for mutations and homozygous deletions in the coding region of the hSNF5/INI1 gene and for allelic loss of its flanking chromosomal regions in 39 ependymal tumors of 35 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329523.RAYY-fSNvdRlg3pYaHiP5wCaI6G6ibaSmMN8MrV2y7-w8130_provenance.
- NP329522.RA4JH5IIKGy2pnYT8ly_nPe9a120y7zbSxEWwXnDxR7og130_assertion description "[In addition, this gene may be responsible for a new hereditary syndrome predisposing to a variety of tumors designated rhabdoid predisposition syndrome. In the present study, we analyzed a series of 53 ependymal tumors of 48 patients [4 myxopapillary ependymomas (WHO grade I), 3 subependymomas (WHO grade I), 18 ependymomas (WHO grade II), 21 anaplastic ependymomas (WHO grade III) and 2 ependymoblastomas (WHO grade IV)] for mutations and homozygous deletions in the coding region of the hSNF5/INI1 gene and for allelic loss of its flanking chromosomal regions in 39 ependymal tumors of 35 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329522.RA4JH5IIKGy2pnYT8ly_nPe9a120y7zbSxEWwXnDxR7og130_provenance.